A Message from Symbio’s CEO
At Symbio, our clients are the core of everything we do. We recognize the significant responsibility of bringing drugs and devices to market, and we are truly honored to be chosen as a partner to help guide this critical journey. With a vast network of experts across specialized therapeutic areas and global regions, we provide customized solutions tailored to meet the unique needs of each client. Our reputation is built on the principle that ‘the reward for good work is more work,’ and we remain dedicated to delivering exceptional customer service every step of the way.
-Alan Morgan, Symbio CEO
Headquartered in Port Jefferson, NY, Symbio is a client-focused global full-service Clinical Research Organization (CRO) with strong focus on dermatology and inflammatory diseases. We manage all CRO core services in-house and have our offices in the USA and Europe. We deliver excellent service and provide experienced qualified personnel to strategically manage all aspects of your clinical trials. In November of 2023, NY-headquartered Symbio, LLC and CA-headquartered Dow Development Laboratories, LLC merged with Münster (Germany)-based Proinnovera. This merger created one of the world’s largest specialized dermatology-focused clinical research organization. In September of 2024, after a successful integration process, the group was renamed from Symbio Proinnovera to Symbio. Symbio offers expertise in Proof-of-Concept, medical device and Phase 1 – Phase 4 clinical studies and has completed over 650+ clinical studies to date, both in the USA and in Europe. Developing and maintaining excellent relationships with experienced clinical research sites are vital to the success of any study and every CRO. As a direct result of our site relationships, Symbio trials receive the special attention they deserve. We take great pride in the strong relationships we have established over the years. These relationships have provided us the ability to streamline recruitment, creating shorter enrollment timelines with a lower number of sites.
Our Core Services
- Regulatory Affairs
- Protocol Development
- Project Management
- Medical Monitoring
- Site Monitoring and Management
- Data Management
- Biostatistics
- Medical Writing
- Subject Recruitment